| Entry |
|
|---|
| Name |
Oxymorphone hydrochloride (USP);
Numorphan (TN);
Opana (TN) |
|---|
| Product |
|
|---|
| Generic |
OXYMORPHONE HYDROCHLORIDE (Amneal Pharmaceuticals LLC), OXYMORPHONE HYDROCHLORIDE (Amneal Pharmaceuticals of New York LLC), OXYMORPHONE HYDROCHLORIDE (Aurolife Pharma), OXYMORPHONE HYDROCHLORIDE (Bryant Ranch Prepack), OXYMORPHONE HYDROCHLORIDE (Bryant Ranch Prepack), OXYMORPHONE HYDROCHLORIDE (Camber Pharmaceuticals), OXYMORPHONE HYDROCHLORIDE (Epic Pharma), OXYMORPHONE HYDROCHLORIDE (Hikma Pharmaceuticals USA), OXYMORPHONE HYDROCHLORIDE (KVK-Tech), OXYMORPHONE HYDROCHLORIDE (Lake Erie Medical DBA Quality Care Products LLC), OXYMORPHONE HYDROCHLORIDE (XLCare Pharmaceuticals) |
|---|
| Formula |
C17H19NO4. HCl
|
|---|
| Exact mass |
337.1081
|
|---|
| Mol weight |
337.798
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Neuropsychiatric agent
DG01564 Opioid receptor agonist
DG01563 mu-Opioid receptor agonist
Analgesic
DG01984 Opioid analgesics
|
|---|
| Remark |
| Product (DG01343): | D00844<US> |
|
|---|
| Efficacy |
Analgesic (narcotic), Opioid receptor agonist |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07224 | Opioid receptor agonists/antagonists |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N02 ANALGESICS
N02A OPIOIDS
N02AA Natural opium alkaloids
N02AA11 Oxymorphone
D00844 Oxymorphone hydrochloride (USP) <US>
USP drug classification [BR:br08302]
Analgesics
Opioid Analgesics, Long-acting
Oxymorphone
D00844 Oxymorphone hydrochloride (USP)
Opioid Analgesics, Short-acting
Oxymorphone
D00844 Oxymorphone hydrochloride (USP)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01564 Opioid receptor agonist
DG01563 mu-Opioid receptor agonist
DG01343 Oxymorphone
D00844 Oxymorphone hydrochloride
Analgesic
DG01984 Opioid analgesics
DG01343 Oxymorphone
D00844 Oxymorphone hydrochloride
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Opioid
OPRM1
D00844 Oxymorphone hydrochloride (USP) <US>
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01564 Opioid receptor agonist
DG01563 mu-Opioid receptor agonist
DG01343 Oxymorphone
Analgesic
DG01984 Opioid analgesics
DG01343 Oxymorphone
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 23
1 X Cl 28.8996 -15.0125
2 C1z C 23.5917 -17.6850
3 C8y C 23.5857 -16.3337
4 C1z C 24.7573 -18.3521
5 C1y C 22.4376 -18.3637
6 C8y C 22.4201 -15.6610
7 C8y C 24.7515 -15.6610
8 C1y C 25.9174 -17.6677
9 C1x C 24.7630 -19.6859
10 O1a O 25.9174 -19.2917
11 O2x O 21.7357 -17.0300
12 C5x C 22.4433 -19.6975
13 C8y C 22.4201 -14.3156
14 C1x C 25.9174 -16.3278
15 C8x C 24.7515 -14.3156
16 N1y N 27.0771 -18.3403
17 C1x C 23.6090 -20.3645
18 O5x O 21.2660 -20.3586
19 C8x C 23.5857 -13.6429
20 O1a O 21.2486 -13.6429
21 C1a C 28.4226 -18.3403
22 C1x C 27.0771 -17.0172
23 C1x C 24.7979 -16.9886
BOND 26
1 2 3 1
2 2 4 1
3 2 5 1
4 3 6 1
5 3 7 2
6 4 8 1
7 4 9 1
8 4 10 1 #Up
9 5 11 1 #Down
10 5 12 1
11 6 13 2
12 7 14 1
13 7 15 1
14 8 16 1 #Up
15 9 17 1
16 12 18 2
17 13 19 1
18 13 20 1
19 16 21 1
20 6 11 1
21 8 14 1
22 12 17 1
23 15 19 2
24 2 23 1 #Up
25 23 22 1
26 16 22 1 #Up
|
|---|
